We are live on ! Find out more
Amundi

Amundi Portfolio holdings

AUM $445B Turnover 8.9%
1-Year Est. Return 36.51%
 

Amundi is a French asset manager formed in 2010 when Crédit Agricole and Société Générale combined their fund management businesses. Its roots go back to 1996, when Crédit Agricole created its asset management subsidiary. It runs mutual funds, index funds and ETFs, and Crédit Agricole remains its majority shareholder. Amundi has grown by acquisition, announcing the purchase of Pioneer Investments, the asset management arm of Italian bank UniCredit, in 2016 and of Lyxor, a business bought from Société Générale, in 2021. In 2025 Amundi combined its US business with Victory Capital and became a strategic shareholder in that firm.

This Fund
S&P 500
This Quarter Est. Return
+0.66%
1 Year Est. Return
+36.51%
3 Year Est. Return
+142.38%
5 Year Est. Return
+174.77%
10 Year Est. Return
+683.06%
AUM
$27.4B
AUM Growth
-$602M
Cap. Flow
-$1.01B
Cap. Flow %
-3.68%
Top 10 Hldgs %
18.13%
Holding
664
New
68
Increased
207
Reduced
265
Closed
47
Avg Time Held
1.3 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1 year

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Financials 16%
3 Technology 12.74%
4 Industrials 9.73%
5 Consumer Discretionary 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$4.98T
$840M 3.07%
26,802,168
-382,248
-1% -$12.2M
2013 Q2
8 quarters
MSFT icon
2
Microsoft
MSFT
$3.6T
$728M 2.66%
16,489,346
-264,370
-2% -$12.1M
2013 Q2
8 quarters
CVS icon
3
CVS Health
CVS
$103B
$576M 2.11%
5,490,251
+43,422
+0.8% +$4.44M
2013 Q2
8 quarters
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.25T
$539M 1.97%
20,303,600
+1,004,260
+5% +$26.9M
2013 Q2
8 quarters
DIS icon
5
Walt Disney
DIS
$202B
$488M 1.78%
4,271,764
+61,554
+1% +$6.76M
2013 Q2
8 quarters
CELG
6
DELISTED
Celgene
CELG
$408M 1.49%
3,523,050
+47,803
+1% +$5.47M
2013 Q2
8 quarters
GILD icon
7
Gilead Sciences
GILD
$206B
$383M 1.4%
3,274,401
+227,713
+7% +$24.9M
2013 Q2
8 quarters
ROST icon
8
Ross Stores
ROST
$68.2B
$347M 1.27%
7,146,147
-118,893
-2% -$5.98M
2013 Q2
8 quarters
EMC icon
9
DELISTED
EMC
EMC
$332M 1.21%
12,569,670
+659,133
+6% +$17.6M
2013 Q2
8 quarters
WFC icon
10
Wells Fargo
WFC
$236B
$318M 1.16%
5,648,894
-1,787,498
-24% -$100M
2013 Q2
8 quarters
HD icon
11
Home Depot
HD
$338B
$308M 1.13%
2,769,743
+65,421
+2% +$7.32M
2013 Q2
8 quarters
RTX icon
12
RTX
RTX
$257B
$293M 1.07%
2,640,938
-354,692
-12% -$41.4M
2013 Q2
8 quarters
ESRX
13
DELISTED
Express Scripts Holding
ESRX
$292M 1.07%
3,284,704
+411,589
+14% +$36M
2013 Q2
8 quarters
TMO icon
14
Thermo Fisher Scientific
TMO
$248B
$282M 1.03%
2,171,128
+32,142
+2% +$4.19M
2013 Q2
8 quarters
SBUX icon
15
Starbucks
SBUX
$118B
$272M 0.99%
5,071,980
-244,008
-5% -$12.4M
2013 Q2
8 quarters
MA icon
16
Mastercard
MA
$545B
$261M 0.95%
2,793,058
+72,429
+3% +$6.65M
2013 Q2
8 quarters
JPM icon
17
JPMorgan Chase
JPM
$825B
$254M 0.93%
3,754,233
+3,428,626
+1,053% +$224M
2013 Q2
8 quarters
ECL icon
18
Ecolab
ECL
$82.7B
$252M 0.92%
2,232,093
+267,696
+14% +$30.8M
2013 Q2
8 quarters
ICE icon
19
Intercontinental Exchange
ICE
$95B
$252M 0.92%
5,626,790
+622,790
+12% +$28.9M
2014 Q1
5 quarters
AET
20
DELISTED
Aetna Inc
AET
$250M 0.91%
1,959,240
-359,262
-15% -$41M
2013 Q2
8 quarters
MMM icon
21
3M
MMM
$91.8B
$236M 0.86%
1,530,840
-130,252
-8% -$20.9M
2013 Q2
8 quarters
MS icon
22
Morgan Stanley
MS
$259B
$234M 0.86%
6,034,540
+487,763
+9% +$18.6M
2013 Q2
8 quarters
CAH icon
23
Cardinal Health
CAH
$63.1B
$229M 0.84%
2,732,113
-358,827
-12% -$31.7M
2013 Q2
8 quarters
PARA icon
24
DELISTED
Paramount Global Class B
PARA
$219M 0.8%
3,943,927
+1,605,484
+69% +$97M
2013 Q2
8 quarters
AGN
25
DELISTED
Allergan plc
AGN
$216M 0.79%
711,397
+118,493
+20% +$35.3M
2013 Q2
8 quarters

Similar funds

Amundi's Q2 2015 Portfolio in Review

As of Q2 2015, Amundi held 664 positions worth $27.4B, down 2.2% from $28B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Amundi withdrew a net $1.01B in Q2 2015, closing 47 positions and reducing 265 holdings. Its most notable exit was Lorillard, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Technology.

Against the trend, Amundi opened a new position in Reynolds American worth $181M.

  • Amundi's largest Q2 2015 buy was Reynolds American: 4,856,374 shares worth $181M.
  • Amundi added most to JPMorgan Chase in Q2 2015, an estimated $224M increase.
  • Amundi's biggest Q2 2015 reduction was PNC Financial Services, cutting an estimated $150M.
  • Amundi fully exited Lorillard in Q2 2015, selling an estimated $210M.
  • Amundi's ten largest holdings make up 18% of its $27.4B portfolio in Q2 2015.
  • Amundi opened 68 new positions and closed 47 in Q2 2015.
  • Amundi's portfolio value fell 2.2% quarter-over-quarter to $27.4B.

Based on Amundi's 13F filing for Q2 2015, filed 6 Aug 2015.